Amelie-eHealthAI
commited on
Commit
•
fb24b72
1
Parent(s):
c1915cb
Update README.md
Browse files
README.md
CHANGED
@@ -20,6 +20,11 @@ datasets:
|
|
20 |
## - **https://trialmatchllm.com/**
|
21 |
## ************************************************
|
22 |
|
|
|
|
|
|
|
|
|
|
|
23 |
|
24 |
Synthetic Cases Dataset - Microbiome-based therapeutics
|
25 |
|
@@ -30,6 +35,7 @@ Synthetic Cases Dataset - Microbiome-based therapeutics
|
|
30 |
![image/png](https://cdn-uploads.huggingface.co/production/uploads/6569e9d4d9f52520c827a0b4/SnN6_1eaVB4kILJl7Gb5o.png)
|
31 |
|
32 |
|
|
|
33 |
# Finetuning
|
34 |
base template used for fine-tuning: https://colab.research.google.com/drive/1D6OsKMp2zI9b2EWb_dfH-3clEVo7A5QK?usp=sharing#scrollTo=ZYLl8EJmTRL2
|
35 |
|
|
|
20 |
## - **https://trialmatchllm.com/**
|
21 |
## ************************************************
|
22 |
|
23 |
+
## Example Usage
|
24 |
+
Input:
|
25 |
+
|
26 |
+
"A 30-year-old male, recently diagnosed with Crohn's disease in Copenhagen, Scandinavia, is collaborating with his gastroenterologist at Rigshospitalet. Microbiome sequencing has unveiled an altered composition characterized by increased levels of Escherichia coli. The Multidisciplinary Team suspects a potential correlation between this microbial profile and responses to immunosuppressive medications commonly used in Crohn's disease treatment. Actively seeking clinical trials in Scandinavia, the team aims to explore microbiome-based interventions that could enhance drug response and improve outcomes for individuals with inflammatory bowel disorders"
|
27 |
+
|
28 |
|
29 |
Synthetic Cases Dataset - Microbiome-based therapeutics
|
30 |
|
|
|
35 |
![image/png](https://cdn-uploads.huggingface.co/production/uploads/6569e9d4d9f52520c827a0b4/SnN6_1eaVB4kILJl7Gb5o.png)
|
36 |
|
37 |
|
38 |
+
|
39 |
# Finetuning
|
40 |
base template used for fine-tuning: https://colab.research.google.com/drive/1D6OsKMp2zI9b2EWb_dfH-3clEVo7A5QK?usp=sharing#scrollTo=ZYLl8EJmTRL2
|
41 |
|